Trial Profile
A retrospective, cohort, comparative effectiveness study of ceftaroline and daptomycin as first-line therapy for patients with skin and soft tissue infections admitted to hospitals in the united states veterans health care system.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2016
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary) ; Daptomycin
- Indications Skin and soft tissue infections
- Focus Therapeutic Use
- 27 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016